Clinical Trial

To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy Subjects

Name: To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy Subjects — clinical trial record (NCT07588906)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to compare the pharmacodynamic profile of a single subcutaneous dose of SHR-3167 injection versus insulin glargine U100 in healthy subjects.

Trial Details

NCT Number	NCT07588906
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Healthy Subjects
Enrollment	24 participants
Start Date	2024-02-26
Primary Completion	2024-07-12 (estimated)
Study Completion	2024-07-23 (estimated)
Updated on ClinicalTrials.gov	2026-05-15